DEC 02, 2015 05:05 PM PST

A New Remedy for Whooping Cough

WRITTEN BY: Kerry Evans
1 21 1517
Researchers at The University of Texas at Austin, in collaboration with Synthetic Biologics Inc., developed an antibody-based therapy for whooping cough.

Whooping cough is a bacterial infection caused by Bordetella pertussis.  Antibiotics are not always effective and it is highly contagious, infecting nearly 16 million people each year worldwide.  B. pertussis is particularly virulent because it produces a toxin.  Pertussis toxin (PT) enters cells where it prevents G proteins from interacting with G protein-coupled receptors, shutting down many vital cellular processes. PT also causes lymphocytosis, an increase in white blood cells in the blood.  These white blood cells interfere with lung function and contribute to the characteristic cough.  While there is a vaccine, it is not licensed for use in infants under 6 weeks of age.
 
Whooping cough is caused by Bordetella pertussis.
 
With this in mind, the University of Texas researchers, led by chemical engineer Jennifer Maynard, developed two antibodies that neutralize PT.  The antibodies bind the toxin, preventing it from attaching to and entering cells.  When the group injected mice with the antibodies then infected them with B. pertussis, they were protected from infection.  The group then infected non-human primates and administered the antibodies.  In this case, the antibody treatment decreased white blood cell levels and sped up recovery.    
According to Maynard, “in the developing world, an estimated 200,000 babies die a year, and that's where we think we can have a really big impact … if we can get our antibodies to these high-risk infants, we could potentially prevent the infection from occurring in the first place”.  The group licensed the antibodies to Synthetic Biologics Inc., and they hope to begin human clinical trials soon.  

While this new antibody-based therapy sounds promising, I’m left with a lingering question.  Will Synthetic Biologics be able to distribute their antibody therapy to the developing world even though (evidently) the whooping cough vaccine hasn’t made it there?  Guess we’ll wait and see.

Sources: Eurekalert, Synthetic Biologics, Inc., Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUN 07, 2018
Videos
JUN 07, 2018
Nipah Virus Outbreak in India Kills 17
Nipah virus, an emerging infection, was detected recently for the first time in southern India.
JUN 11, 2018
Microbiology
JUN 11, 2018
Seeing Gene Transfer as it Happens
Microbes can pick up new pieces of genetic material; now it's been captured in action for the first time.
JUN 13, 2018
Immunology
JUN 13, 2018
Vitamin A Gives Immune System Power to Fight Tuberculosis
Multidrug-resistant tuberculosis bacteria are a serious health concern for the global population, but a new finding offers a new therapeutic solution that
JUN 28, 2018
Microbiology
JUN 28, 2018
Stopping Bacterial Spores From Getting Into Space
Researchers want to stop the contamination of extraterrestrial environments by earthly bacteria.
JUL 03, 2018
Immunology
JUL 03, 2018
Here's a Virus that Boosts the Immune System
There’s a new therapeutic approach to boosting the weakened immune system that develops naturally with age, but it’s anything but conventional.
AUG 05, 2018
Microbiology
AUG 05, 2018
The War Beneath Our Feet
The bacteria living in the soils of Earth seem locked in battle with the fungi there.
Loading Comments...